MoneyWorks4Me

AstraZeneca Pharma India informs about closure of trading window

17 Jun 2022 Evaluate

In accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, AstraZeneca Pharma India has informed that the Trading Window for dealing in the Shares of the Company remains closed from June 16, 2022 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter ending June 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..